Alnylam Pharmaceuticals | Bienes



Assets Cambio Fecha
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amgen USD 87.9B 1.47B 2025-06
Arrowhead Research USD 1.38B 192.89M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Incyte USD 5.82B 71.99M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
Moderna USD 12.01B 694M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Novartis USD 102.25B 1.28B 2024-12
PTC Therapeutics USD 2.63B 21.23M 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Sanofi 132.8B 3.04B 2024-12
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
Takeda JPY 14T 243.81B 2025-06
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
Ultragenyx Pharmaceutical USD 1.31B 5.66M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06
Xencor USD 879.42M 25.26M 2025-06


Alnylam Pharmaceuticals Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.